$38.96
0.36% day before yesterday
NYSE, Sep 06, 10:10 pm CET
ISIN
US0718131099
Symbol
BAX

Baxter International Stock price

$38.96
+2.04 5.53% 1M
-4.03 9.37% 6M
+0.30 0.78% YTD
-0.68 1.72% 1Y
-43.75 52.90% 3Y
-50.82 56.61% 5Y
-1.36 3.37% 10Y
NYSE, Closing price Fri, Sep 06 2024
+0.14 0.36%
ISIN
US0718131099
Symbol
BAX
Sector

Key metrics

Market capitalization $19.88b
Enterprise Value $31.19b
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 60.21
EV/Sales (TTM) EV/Sales 2.08
P/S ratio (TTM) P/S ratio 1.33
P/B ratio (TTM) P/B ratio 2.60
Dividend yield 2.98%
Last dividend (FY23) $1.16
Revenue growth (TTM) Revenue growth -0.13%
Revenue (TTM) Revenue $15.00b
EBIT (operating result TTM) EBIT $1.51b
Free Cash Flow (TTM) Free Cash Flow $518.00m
Cash position $2.10b
EPS (TTM) EPS $-0.80
P/E forward 22.18
P/S forward 1.31
EV/Sales forward 2.05
Short interest 2.24%
Show more

Is Baxter International a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,914 stocks worldwide.

Baxter International Stock Analysis

Unlock Scores for Free

Analyst Opinions

16 Analysts have issued a Baxter International forecast:

4x Buy
25%
11x Hold
69%
1x Sell
6%

Analyst Opinions

16 Analysts have issued a Baxter International forecast:

Buy
25%
Hold
69%
Sell
6%

Financial data from Baxter International

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '24
+/-
%
14,997 14,997
0% 0%
100%
- Direct Costs 9,441 9,441
1% 1%
63%
5,556 5,556
2% 2%
37%
- Selling and Administrative Expenses 2,122 2,122
2% 2%
14%
- Research and Development Expense 662 662
6% 6%
4%
2,772 2,772
1% 1%
18%
- Depreciation and Amortization 1,258 1,258
3% 3%
8%
EBIT (Operating Income) EBIT 1,514 1,514
4% 4%
10%
Net Profit -406 -406
86% 86%
-3%

In millions USD.

Don't miss a Thing! We will send you all news about Baxter International directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Baxter International Stock News

Neutral
GlobeNewsWire
5 days ago
Management provides view on recently announced Vantive-Carlyle Group transaction Management provides view on recently announced Vantive-Carlyle Group transaction
Neutral
Business Wire
10 days ago
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the 2024 Wells Fargo Healthcare Conference on Thursday, September 5, 2024. Joel Grade, Baxter's chief financial officer, is scheduled to present at 1:30 p.m. Eastern Time. The live webcast of Baxter's presentation can be accessed at www.baxter.com and will be available for replay thr...
Positive
Forbes
19 days ago
On August 13, 2024, Baxter International Inc. (NYSE: BAX, $36.12, Market Capitalization: $18.4 billion), a global medtech leader, and funds managed by global investment firm Carlyle (NASDAQ: CG) announced that they have signed a definitive agreement under which Carlyle will acquire Baxter's Kidney Care segment, to be named Vantive, for $3.8 billion (For details refer to spinoffresearch.com). Un...
More Baxter International News

Company Profile

Baxter International, Inc. provides portfolio of essential renal and hospital products, including acute and chronic dialysis, sterile IV solutions, infusion systems and devices, parenteral nutrition therapies; premixed and oncolytic injectable, bio surgery products and anesthetics, drug reconstitution systems and pharmacy automation, software and services. It operates through the following segment: Americas, Europe, Middle East & Africa and Asia-Pacific. The company was founded by Davis Baxter in 1931 and is headquartered in Deerfield, IL.

Head office United States
CEO Joe Almeida
Employees 60,000
Founded 1931
Website www.baxter.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today